J Michael Dixon

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Locally Advanced

Sentinel Lymph Node

Ejection Fraction

Top Venues

EMBO molecular medicine

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine (2024)
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO molecular medicine 16 (4) (2024)
J Michael Dixon, Julia Grewar, Dominique Twelves, Ashley Graham, Carlos Martinez-Perez, Arran Turnbull
Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer. Breast cancer research and treatment 184 (2) (2020)